Opioid drug conversion guidelines vary and conflict, study says

05/14/2013 | MedPage Today (free registration)

Guidelines for opioid drug conversion vary and sometimes conflict, and are based on single-dose studies that lack long-term data, according to a Purdue Pharma study presented at APS' 32nd Annual Scientific Meeting. The biggest variation was found in recommendations for hydromorphone and oxycodone. Dr. John Peppin of the Palliative Care Center in Lexington, Ky., agreed there is a problem, and said physicians are aware of it.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX